Free ACDIS CCDS Practice Exam with Questions & Answers | Set: 4

The mortality ratio is the option most directly associated with patient outcome measurement and risk-adjusted quality reporting. Although the question uses the phrase expected/observed mortality ratio, mortality analytics are frequently expressed operationally as an observed-to-expected (O/E) mortality ratio. Documentation affects the expected component because severity-of-illness and risk-of-mortality models depend substantially on accurately reported diagnoses and comorbid conditions.

If important acute or chronic conditions are not documented or are insufficiently specified, coded data may portray a patient as less severely ill than the clinical reality. The expected mortality calculated by a risk-adjustment model may therefore be lower, potentially making actual mortality performance appear less favorable. This makes mortality analysis particularly useful when teaching physicians why documentation affects quality measures independently of reimbursement.

CC/MCC capture is useful for examining documentation and reimbursement performance but is not itself an outcome measure. Monthly review volume is a productivity metric, while CDI/coder agreement evaluates internal process performance.

The CCDS examination content specifically includes mortality reviews, interpretation of observed/expected ratios, severity of illness, risk of mortality, and documentation effects on publicly reported quality data.

CCDS Reference Topics: Impact of reportable diagnoses on quality of care; SOI/ROM; mortality index; physician education.

=========

The CDI specialist should seek greater specificity regarding the pneumonia. The abbreviation HCAP historically referred to “healthcare-associated pneumonia,” but that terminology does not identify a causative organism or a sufficiently specific ICD-10-CM pneumonia diagnosis.

From a CDI perspective, the clinically relevant clarification may involve whether the pneumonia is bacterial, viral, aspiration-related, gram-negative, due to a specific organism, or otherwise characterized by the provider based on the available evidence. Culture results, aspiration risk, recent healthcare exposure, antibiotic selection, radiology, respiratory cultures, and infectious-disease documentation may provide appropriate clinical indicators for a neutral query.

Simply assigning a generic pneumonia working code fails to resolve the documentation deficiency. Asking only whether HCAP means “healthcare-acquired pneumonia” merely expands the abbreviation without producing useful etiologic specificity. “Complex pneumonia” is not an appropriate substitute diagnostic classification.

The CDI specialist must also avoid assuming that recent healthcare exposure establishes resistant-organism pneumonia. Contemporary clinical practice has moved away from treating HCAP as a standalone etiologic category because exposure alone does not reliably establish a particular pathogen.

CCDS Reference Topics: Pneumonia specificity; abbreviations; diagnostic clarification; compliant provider queries.

=========

Taking more medication than prescribed constitutes poisoning under ICD-10-CM drug-event rules. The drug may have been correctly prescribed, but the patient took an incorrect amount.

For poisoning, the applicable poisoning code is generally sequenced first, followed by codes identifying manifestations such as gastrointestinal bleeding.

This differs from an adverse effect, in which a drug is correctly prescribed and properly administered but causes an undesirable reaction. In adverse-effect scenarios, the nature of the adverse effect is coded first, followed by the drug code with the appropriate adverse-effect character.

Underdosing applies when the patient takes less of a medication than prescribed, whether intentionally or unintentionally. It does not describe excessive dosing.

For CDI specialists, determining whether an event represents poisoning, adverse effect, or underdosing requires careful review of how the medication was prescribed and actually taken. Phrases such as “warfarin-related bleeding” may not always provide enough information to determine the correct classification.

A clarification query may therefore be appropriate when dose, intent, or medication-use circumstances are unclear.

CCDS Reference Topics: Poisoning; adverse effects; underdosing; medication events; sequencing.

=========

The findings strongly support a clarification opportunity for acute hypercapnic respiratory failure. The patient has a substantial acute rise in PaCO₂ above the documented baseline, respiratory acidemia with a pH of 7.27, hypoxemia, altered mental status, respiratory distress, and escalation to noninvasive ventilatory support.

In chronic CO₂ retention, renal compensation commonly increases serum bicarbonate and may allow a relatively preserved pH. A pronounced fall in pH in conjunction with a significant increase in PaCO₂ suggests an acute ventilatory deterioration. The need for BiPAP provides additional evidence of clinically significant respiratory compromise.

Option C is incorrect because the acidemia is driven primarily by elevated carbon dioxide, indicating respiratory rather than metabolic acidosis. Option A fails to capture the apparent acute deterioration from the patient's baseline. Option D is inconsistent with the physiologic abnormalities and treatment intensity.

The CDI specialist must still obtain provider documentation rather than independently diagnose respiratory failure. The CCDS examination specifically includes acute/chronic respiratory failure, COPD, ventilation support, and diagnostic-test interpretation among expected clinical competencies.

CCDS Reference Topics: Acute respiratory failure; hypercapnia; ABG interpretation; COPD; noninvasive ventilation.

=========

The record contains a significant clinical-documentation discrepancy. A TIA is characterized by transient neurologic dysfunction without acute infarction, whereas this patient's MRI demonstrates an acute cerebral infarction and the patient continues to have a persistent focal neurologic deficit.

Therefore, the provider should be asked to clarify the final diagnosis.

The CDI specialist cannot independently replace TIA with cerebral infarction, even though the clinical findings strongly favor an infarction. Provider documentation must reconcile the diagnostic evidence.

Automatically reporting both conditions could also misrepresent the encounter when one diagnosis has effectively been superseded by subsequent findings.

The query should objectively present the initial TIA documentation, MRI-confirmed infarction, persistent right-sided weakness, and resolution of aphasia, then ask the physician to clarify the final neurologic diagnosis.

This scenario illustrates why concurrent CDI review must continue beyond initial admission documentation. Early diagnoses may evolve as diagnostic testing becomes available.

Accurate stroke documentation affects principal diagnosis, severity representation, rehabilitation planning, risk adjustment, quality reporting, and longitudinal patient history.

CCDS Reference Topics: Cerebral infarction; TIA; imaging; conflicting documentation; diagnostic evolution.

=========

The provider query response rate is calculated by dividing answered queries by total queries issued:

720 ÷ 800 × 100 = 90%.

Therefore, the correct answer is 90%.

The 540 responses agreeing with the clarification are relevant to a different measure: provider agreement rate. If agreement were calculated against answered queries, it would be 540 ÷ 720 = 75%.

These metrics should not be confused. Response rate measures whether providers participate in the clarification process, whereas agreement rate measures the proportion of responses that substantively agree with the diagnosis or clarification being evaluated.

A lower agreement rate is not necessarily evidence of poor CDI performance. Providers should remain free to disagree, document another supported diagnosis, rule out a condition, or indicate that the issue cannot be determined.

A CDI manager should trend response rate, agreement rate, response time, unanswered-query aging, retrospective-query percentage, and query type together rather than judging program success from a single number.

The 2026 ACDIS/AHIMA guidance reinforces provider independence as a fundamental aspect of a compliant query process.

CCDS Reference Topics: Query response rate; agreement rate; CDI metrics; provider engagement; program analysis.

The record presents a legitimate opportunity to clarify the type or etiology of pneumonia, particularly whether aspiration contributed to the pulmonary infection. Dysphagia following stroke, documented aspiration during oral intake, fever, hypoxia, and a dependent-lobe infiltrate form a clinically relevant pattern.

However, the CDI specialist cannot independently convert unspecified pneumonia into aspiration pneumonia. Likewise, the speech-language pathologist can provide valuable clinical evidence regarding swallowing dysfunction and aspiration risk, but that documentation does not independently establish the medical diagnosis of aspiration pneumonia for coding purposes.

A compliant query should objectively present the pertinent indicators and allow the provider to identify aspiration pneumonia, another pneumonia type, pneumonitis, another condition, or inability to determine.

Automatically assigning both bacterial and aspiration pneumonia would also be inappropriate because neither bacterial etiology nor a separate second pneumonia diagnosis has been established.

The current ACDIS/AHIMA guidance emphasizes that queries should arise from the clinical record and preserve the provider's independent judgment rather than directing a preferred diagnosis.

CCDS Reference Topics: Pneumonia specificity; aspiration; dysphagia; interdisciplinary documentation; compliant query development.

=========

This scenario requires a clinical validation query. The diagnosis of respiratory failure is documented, but the remainder of the record lacks clinical evidence supporting it. CDI should not automatically accept the diagnosis solely because it appears in a progress note, nor should the specialist unilaterally remove or invalidate the provider's diagnosis.

The appropriate process is to present relevant patient-specific clinical information objectively and ask the responsible provider to clarify whether respiratory failure remains clinically appropriate. A compliant validation query should permit the provider to confirm the diagnosis, document another condition, indicate that it was ruled out, or provide another clinically appropriate response.

Looking only for CPAP documentation is inadequate because CPAP can be used for multiple conditions and its presence or absence does not independently determine whether respiratory failure exists. Similarly, simply refusing to code the diagnosis without seeking clarification bypasses the provider's clinical judgment and the organization's validation process.

The 2026 ACDIS/AHIMA query guidance is now the current foundational standard and supersedes earlier versions of the practice brief.

CCDS Reference Topics: Clinical validation; compliant querying; unsupported diagnoses; documentation integrity.

=========

POA status is determined in relation to the time of inpatient admission, not the patient's physical arrival at the hospital. Therefore, a condition that develops during outpatient surgery, emergency-department care, or observation and remains present when the inpatient admission order occurs is generally considered present on admission for inpatient POA reporting.

This concept can be counterintuitive because the condition technically developed after the patient entered the hospital building. However, CMS's POA framework distinguishes outpatient care from the subsequent inpatient admission.

The fact that the condition is a complication does not automatically make it POA = N. POA status and classification as a complication are separate concepts.

A “U” indicator signifies insufficient documentation to determine whether the condition was present at admission; it should not be selected merely because a condition arose during outpatient care before admission.

CDI specialists frequently need to establish precise clinical timelines involving emergency services, observation, procedures, admission orders, and onset of complications. Clear timing supports accurate POA assignment and is especially important when diagnoses intersect with CMS HAC payment logic.

The CCDS framework specifically expects knowledge of POA and inpatient reimbursement regulations.

CCDS Reference Topics: POA; outpatient-to-inpatient transition; admission timing; HAC policy.

=========

The maximum payment reduction under the Hospital Readmissions Reduction Program is 3%. CMS expresses this through a payment adjustment factor ranging from 1.0, indicating no reduction, to 0.97, representing the maximum 3% reduction.

The HRRP links Medicare payment to excess readmission performance for specified clinical populations. CMS applies the resulting adjustment to applicable Medicare fee-for-service base operating DRG payments.

This program should not be confused with other Medicare hospital quality-payment initiatives. The HAC Reduction Program imposes a 1% reduction on hospitals in the worst-performing quartile, while Hospital Value-Based Purchasing uses a 2% reduction-and-redistribution mechanism.

CMS's FY 2026 IPPS final rule also finalized changes to HRRP methodology that begin with the FY 2027 program year, including incorporation of Medicare Advantage data into the six readmission measures and shortening the applicable performance period from three years to two.

For CDI, the central obligation remains ensuring that the clinical record accurately portrays patient severity, conditions treated, discharge circumstances, and comorbid disease burden.

CCDS Reference Topics: HRRP; readmission measures; quality reimbursement; payment adjustments; risk adjustment.

=========